sydnexis crl fda_thumbnail
October 28, 2025

Sydnexis Receives FDA Complete Response Letter for SYD-101 Pediatric Myopia Treatment

It’s not the “yes” Sydnexis hoped for…but it’s not a “no,” either.  The U.S. Food and Drug Administration (FDA) has…

Glasses deflecting rainbow light rays
October 10, 2025

SightGlass Vision Reports 18-month DOT Lens Data Showing Reduced Myopia Progression

New readout at Academy ’25 adds weight to contrast-modulating spectacle lenses SightGlass Vision (San Ramon, CA, United States) brought fresh…

Discover our fascinating content at issuu

explore